BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25762643)

  • 1. Snail and Slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma.
    Zheng M; Jiang YP; Chen W; Li KD; Liu X; Gao SY; Feng H; Wang SS; Jiang J; Ma XR; Cen X; Tang YJ; Chen Y; Lin YF; Tang YL; Liang XH
    Oncotarget; 2015 Mar; 6(9):6797-810. PubMed ID: 25762643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway.
    Wei T; Cong X; Wang XT; Xu XJ; Min SN; Ye P; Peng X; Wu LL; Yu GY
    Oncotarget; 2017 Jan; 8(4):6663-6680. PubMed ID: 28035060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brucea javanica oil inhibits tongue squamous cell invasion and metastasis by regulating miR-138-EZH2 pathway.
    Jiang L; Zhou J; Wu Y; Zhou L; Zhang C; Zhu J; Fang Z; Shao Y; Wang W
    J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101611. PubMed ID: 37619672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2-Mediated microRNA-139-5p Regulates Epithelial-Mesenchymal Transition and Lymph Node Metastasis of Pancreatic Cancer.
    Ma J; Zhang J; Weng YC; Wang JC
    Mol Cells; 2018 Sep; 41(9):868-880. PubMed ID: 30304920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ΔNp63γ/SRC/Slug Signaling Axis Promotes Epithelial-to-Mesenchymal Transition in Squamous Cancers.
    Srivastava K; Pickard A; Craig SG; Quinn GP; Lambe SM; James JA; McDade SS; McCance DJ
    Clin Cancer Res; 2018 Aug; 24(16):3917-3927. PubMed ID: 29739791
    [No Abstract]   [Full Text] [Related]  

  • 6. Snail controls the mesenchymal phenotype and drives erlotinib resistance in oral epithelial and head and neck squamous cell carcinoma cells.
    Dennis M; Wang G; Luo J; Lin Y; Dohadwala M; Abemayor E; Elashoff DA; Sharma S; Dubinett SM; St John MA
    Otolaryngol Head Neck Surg; 2012 Oct; 147(4):726-32. PubMed ID: 22568942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2 regulates oncomiR-200c and EMT markers in esophageal squamous cell carcinomas.
    Nourmohammadi F; Forghanifard MM; Abbaszadegan MR; Zarrinpour V
    Sci Rep; 2022 Oct; 12(1):18290. PubMed ID: 36316365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis.
    Huang CH; Yang WH; Chang SY; Tai SK; Tzeng CH; Kao JY; Wu KJ; Yang MH
    Neoplasia; 2009 Dec; 11(12):1371-82. PubMed ID: 20019845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mena as a key enhancer factor of EMT to promote metastasis of human tongue squamous cell carcinoma.
    Cui H; Liang X; Zhu Y; Elayah SA; Qi H; Xie L; Guo Z; Siya F; Ming Y; Yuxin G; Tu J; Na S
    Oral Dis; 2024 May; 30(4):2084-2096. PubMed ID: 37203597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma.
    Cheng Y; Song Z; Fang X; Tang Z
    Clin Epigenetics; 2024 Apr; 16(1):54. PubMed ID: 38600608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers.
    Pan M; Schinke H; Luxenburger E; Kranz G; Shakhtour J; Libl D; Huang Y; Gaber A; Pavšič M; Lenarčič B; Kitz J; Jakob M; Schwenk-Zieger S; Canis M; Hess J; Unger K; Baumeister P; Gires O
    PLoS Biol; 2018 Sep; 16(9):e2006624. PubMed ID: 30261040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non‑coding RNA MIR4713HG aggravates malignant behaviors in oral tongue squamous cell carcinoma via binding with microRNA let‑7c‑5p.
    Jia B; Zheng X; Qiu X; Jiang X; Liu J; Huang Z; Xiang S; Chen G; Zhao J
    Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33760127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The competitive mechanism of EZH1 and EZH2 in promoting oral squamous cell carcinoma.
    Chen J; Tang S; Zheng Q; Li J; Jiang H; Lu H; Liao G; Li K; Liang Y
    Exp Cell Res; 2024 Mar; 436(1):113957. PubMed ID: 38309675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETV5 facilitates tumor progression in head-neck squamous cell carcinoma.
    Yu S; Ma Z; Chen T; Wang H; Yao Q; Li J; Cheng J
    Oral Dis; 2024 May; 30(4):2004-2017. PubMed ID: 37649213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epiberberine suppresses the metastasis of head and neck squamous cell carcinoma cells by regulating the MMP-13 and JNK pathway.
    Ho HY; Chen MK; Lin CC; Lo YS; Chuang YC; Hsieh MJ
    J Cell Mol Med; 2023 Dec; 27(23):3796-3804. PubMed ID: 37710409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and role of regulator of G-protein signaling 5 in squamous cell carcinoma of the tongue.
    Abe Y; Ogasawara S; Akiba J; Naito Y; Kondo R; Nakamura K; Kusukawa J; Yano H
    Clin Exp Dent Res; 2019 Apr; 5(2):160-169. PubMed ID: 31049219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit.
    Jiang M; Xu B; Li X; Shang Y; Chu Y; Wang W; Chen D; Wu N; Hu S; Zhang S; Li M; Wu K; Yang X; Liang J; Nie Y; Fan D
    Oncogene; 2019 Jan; 38(3):301-316. PubMed ID: 30093632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of tumor suppressor MTUS1/ATIP is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinoma.
    Ding X; Zhang N; Cai Y; Li S; Zheng C; Jin Y; Yu T; Wang A; Zhou X
    Mol Oncol; 2012 Feb; 6(1):73-80. PubMed ID: 22153618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer.
    Ashrafizadeh M; Hushmandi K; Hashemi M; Akbari ME; Kubatka P; Raei M; Koklesova L; Shahinozzaman M; Mohammadinejad R; Najafi M; Sethi G; Kumar AP; Zarrabi A
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruyiping formula inhibits metastasis via the microRNA-134-SLUG axis in breast cancer.
    Jiang Z; Pei L; Xie Y; Ye Q; Liang X; Ye Y; Liu S
    BMC Complement Med Ther; 2021 Jul; 21(1):191. PubMed ID: 34225726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.